Literature DB >> 33779926

Extracellular Vesicles in Neurological Disorders.

Alex Mazurskyy1, Jason Howitt2,3.   

Abstract

The role of extracellular vesicles (EVs) in the central nervous system, and in particular the brain, is a rapidly growing research area. Importantly, the role for EVs in the nervous system spans from early development through to old age, with EVs being associated with several different neurological disorders. To date, researchers have been studying the function of EVs in the nervous system in three major areas: (i) the role of EVs in promoting disease pathways, (ii) the ability of EVs to be used as a diagnostic tool to identify cellular changes in the nervous system, and (iii) the potential use of EVs as therapeutic tools for the delivery of biomolecules or drugs to the nervous system. In each of these settings the analysis and use of EVs performs a different function, highlighting the breadth of areas in which the EV field is applicable. A key aspect of EV biology is the ability of vesicles to cross biological barriers, in particular the blood brain barrier. This allows for the measurement of serum EVs that contain information about cells in the brain, or alternatively, allows for the delivery of biomolecules that are packaged within EVs for therapeutic use.

Entities:  

Keywords:  Autism (ASD); Brain development; Exosomes; Glioblastoma; Mental health; Neurodegeneration

Mesh:

Year:  2021        PMID: 33779926     DOI: 10.1007/978-3-030-67171-6_16

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  94 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  microRNA-21 regulates astrocytic response following spinal cord injury.

Authors:  Oneil G Bhalala; Liuliu Pan; Vibhu Sahni; Tammy L McGuire; Katherine Gruner; Warren G Tourtellotte; John A Kessler
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

3.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation.

Authors:  Hirohide Asai; Seiko Ikezu; Satoshi Tsunoda; Maria Medalla; Jennifer Luebke; Tarik Haydar; Benjamin Wolozin; Oleg Butovsky; Sebastian Kügler; Tsuneya Ikezu
Journal:  Nat Neurosci       Date:  2015-10-05       Impact factor: 24.884

4.  Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity.

Authors:  James B Adams; Leah J Johansen; Linda D Powell; David Quig; Robert A Rubin
Journal:  BMC Gastroenterol       Date:  2011-03-16       Impact factor: 3.067

Review 5.  Feeding and eating disorders in childhood.

Authors:  Rachel Bryant-Waugh; Laura Markham; Richard E Kreipe; B Timothy Walsh
Journal:  Int J Eat Disord       Date:  2010-03       Impact factor: 4.861

6.  MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.

Authors:  Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Johan Skog; Ichiro Nakano; Sandeep Pingle; Juliya Kalinina; Wei Hua; Santosh Kesari; Ying Mao; Xandra O Breakefield; Fred H Hochberg; Erwin G Van Meir; Bob S Carter; Clark C Chen
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 7.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

8.  Altered Biogenesis and MicroRNA Content of Hippocampal Exosomes Following Experimental Status Epilepticus.

Authors:  Aasia Batool; Thomas D M Hill; Ngoc T Nguyen; Elena Langa; Mairéad Diviney; Catherine Mooney; Gary P Brennan; Niamh M C Connolly; Amaya Sanz-Rodriguez; Brenton L Cavanagh; David C Henshall
Journal:  Front Neurosci       Date:  2020-01-17       Impact factor: 4.677

9.  Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients.

Authors:  Meredith G Banigan; Patricia F Kao; James A Kozubek; Ashley R Winslow; Juan Medina; Joan Costa; Andrea Schmitt; Anja Schneider; Howard Cabral; Ozge Cagsal-Getkin; Charles R Vanderburg; Ivana Delalle
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

Review 10.  From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases.

Authors:  Isabelle Acquatella-Tran Van Ba; Thibaut Imberdis; Véronique Perrier
Journal:  Int J Cell Biol       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.